United States | News & Politics

cross-posted from: https://infosec.pub/post/45005148

For advocates like Lucy Parsons Labs’ Martinez, however, the ultimate solution to ALPRs is the complete abolition of them, not measures made with the intent to improve the existing system.

“I don’t care if they’re secure or not, I don’t want them in my backyard,” Martinez said. “What we’ve seen with these surveillance technologies is that the harms are so great and that all of the ways people have tried to rein them in are so ineffective. If you care about civil liberties, if you care about human rights, if you care about all of these things, you’re going to end up in a place where the answer is ‘we have to just tear these things up.’”

The fundamental problem with ethanol for motor vehicle fuel is that it displaces food for people, resulting in added deforestation. Wind and solar produce far more mobility per acre than ethanol from corn can, while also allowing significant agriculture within their footprint.

In a world where fertilizer or groundwater constrains agriculture, we're far better off using renewables and human food than growing food for cars or airplanes.

Paywall removed https://archive.is/Mn5E5

Does that mean gas prices will go down now?

Cross-Posted, via Photos Community.

“This has never happened before,” one government employee tells WIRED. “I have never gotten a message like this from anyone.”

Archived copies of the article

• Web.archive.org
• Archive.today

The new research is the first to measure community water fluoridation exposure during childhood and any potential impact on cognition up to age 80.

The paper is here. Notably based on people who lived in Wisconsin as kids.

New York Rep. Alexandria Ocasio-Cortez is hustling to win over left-wing critics who say the progressive leader cares too much about mainstream approval and is too cozy with senior Democrats.

Between the lines: If Ocasio-Cortez's diplomacy is successful, it could be more difficult for any potential 2028 presidential candidate to run to her left — but moderate Democrats argue it also could make it tougher for her to win a general election.

Despite her recent efforts, some loud voices on the left — including people who have worked closely with her — have gotten under her skin by continuing to question her progressive bona fides.

Zoom in: In recent weeks, Ocasio-Cortez has tried to repair her relationship with Democratic Socialists of America (DSA). Many members of the group opposed her support for giving Israel defensive weapons, including the Iron Dome missile system, during the war in Gaza — which she has called a "genocide."

In July 2024, national DSA leaders withdrew their endorsement of her for the elections that year, arguing that she'd conflated "anti-Zionism with antisemitism and condemned boycotting Zionist institutions," which the group considered a "deep betrayal."

The intrigue: AOC also has had a fraught relationship with some progressives who helped launch her political career.

Her first chief of staff, Saikat Chakrabarti, co-founded Justice Democrats, a group that helped Ocasio-Cortez with her insurgent House campaign in 2018. Chakrabarti is running for Congress in former House Speaker Nancy Pelosi's district in San Francisco, but Ocasio-Cortez pointedly hasn't endorsed him in the June 2 primary.

She's indicated she believes that some of her early allies on the left have taken too much credit for her upset House victory eight years ago, and she's distanced herself from them over the years, people familiar with the dynamic told Axios.

Faced with high demand for GLP-1 drugs, some American cities and states that previously covered the cost of the weight-loss medication for low-income residents and public employees have now started to restrict or eliminate coverage.

The pullback stems from the dramatic increase in public spending on drugs such as Ozempic and Wegovy in recent years.

Still, some legislators and healthcare providers argue that dropping coverage of the drugs might provide short-term relief for governments but will ultimately harm Medicaid recipients’ health. They argue that cities and states will then have to pay for more health problems related to obesity.

“Patients should have access to these therapies,” said Dr Matthew Klebanoff, a professor of internal medicine at the Perelman School of Medicine who has studied prior authorization policies for GLP-1 drugs. “It’s just very challenging right now for payers to be able to afford covering these medications for everyone who could benefit.”